Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Chiara De Divitiis, Claudia von Arx, Roberto Carbone, Fabiana Tatangelo, Elena Di Girolamo, Giovanni Maria Romano, Alessandro Ottaiano, Elisabetta de Lutio di Castelguidone, Rosario Vincenzo Iaffaioli & Salvatore Tafuto. (2015) A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report. OncoTargets and Therapy 8, pages 669-675.
Read now
Read now
Ron Basuroy, Debashis Sarker, Alberto Quaglia, Rajaventhan Srirajaskanthan & John Ramage. (2015) Personalized Medicine for Gastroenteropancreatic Neuroendocrine Tumors: A Distant Dream?. International Journal of Endocrine Oncology 2:3, pages 201-215.
Read now
Read now
Thorvardur R Halfdanarson, James R Howe, Sigurdis Haraldsdottir & Thomas M O’Dorisio. (2015) Circulating Tumor Markers in Patients with Neuroendocrine Tumors – a Clinical Perspective. International Journal of Endocrine Oncology 2:1, pages 89-99.
Read now
Read now
Raziye Boyar Cetinkaya, Morten Vatn, Lars Aabakken, Deidi S. Bergestuen & Espen Thiis-Evensen. (2014) Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors. Scandinavian Journal of Gastroenterology 49:6, pages 734-741.
Read now
Read now
Simron Singh & Calvin Law. (2012) Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors. Expert Review of Gastroenterology & Hepatology 6:3, pages 313-334.
Read now
Read now
Tine Gregersen, Henning Grønbæk, Jonas Worsøe, Vincent Schlageter, Søren Laurberg & Klaus Krogh. (2011) Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors. Scandinavian Journal of Gastroenterology 46:7-8, pages 895-902.
Read now
Read now
Kristian Bjøro. (2009) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:9, pages 1027-1028.
Read now
Read now
Articles from other publishers (49)
Colleen Achong, Wai Lin Thein, Widz Y Douillard, Madhumati Kalavar & Kirwin Gibbs. (2023) Cracking the Code of a Rare Colonic Mesentery Gastrointestinal Neuroendocrine Tumor Disguised as Chronic Gastroenteritis: The Critical Art of Timely Detection. Cureus.
Crossref
Crossref
Oddry Folkestad, Øyvind Hauso, Patricia Mjønes, Reidun Fougner, Hans H. Wasmuth & Reidar Fossmark. (2023) Survival Trends in Patients with Small Intestinal Neuroendocrine Tumours—A Cohort Study in Central Norway. Cancers 15:13, pages 3272.
Crossref
Crossref
Apostolos Koffas, Alexandros Giakoustidis, Apostolis Papaefthymiou, Petros Bangeas, Dimitrios Giakoustidis, Vasileios N Papadopoulos & Christos Toumpanakis. (2023) Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Frontiers in Surgery 10.
Crossref
Crossref
Detlef K. Bartsch, Elisabeth Maurer & Katharina Holzer. 2023. Endokrine Chirurgie. Endokrine Chirurgie
521
538
.
Jisup Kim, Dong-Hoon Yang, HaeSung Jung, HyungJun Cho, Hyeung-Jin Jang, Changhoon Yoo, In Ja Park, Baek-Yeol Ryoo, Jin-Sook Ryu & Seung-Mo Hong. (2022) Clinicopathologic Impact of Peptide Hormonal Expression in Rectal Neuroendocrine Tumors. Archives of Pathology & Laboratory Medicine.
Crossref
Crossref
Peng Wang, Erlin Chen, Mingjie Xie, Wei Xu, Chaoyang Ou, Zhou Zhou, Yuanjie Niu, Wei Song, Qingfeng Ni & Jianwei Zhu. (2022) The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database. Journal of Gastrointestinal Surgery 26:9, pages 1917-1929.
Crossref
Crossref
Alexandros D. Polydorides & Qingqing Liu. (2022) Evaluation of Pathologic Prognostic Factors in Neuroendocrine Tumors of the Small Intestine. American Journal of Surgical Pathology 46:4, pages 547-556.
Crossref
Crossref
P. Vladova. (2022) MODERN PATHOLOGICAL CONSTELLATION FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS AND IMMUNOHISTOCHEMICAL PANEL. Trakia Journal of Sciences 20:4, pages 346-353.
Crossref
Crossref
Mina M. Swiha, Duncan E. K. Sutherland, Golmehr Sistani, Alireza Khatami, Rami M. Abazid, Amol Mujoomdar, Daniele P. Wiseman, Jonathan G. Romsa, Robert H. Reid & David T. Laidley. (2021) Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS). Journal of Cancer Research and Clinical Oncology 148:1, pages 225-236.
Crossref
Crossref
Detlef K. Bartsch, Elisabeth Maurer & Katharina Holzer. 2021. Viszeral- und Allgemeinchirurgie. Viszeral- und Allgemeinchirurgie
1
18
.
David Wyld, Julie Moore, Nancy Tran & Philippa Youl. (2021) Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001‐2015. Asia-Pacific Journal of Clinical Oncology 17:4, pages 350-358.
Crossref
Crossref
Akie Watanabe, Lily Yip, Trevor D. Hamilton, Jonathan M. Loree & Heather C. Stuart. (2021) Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors. The American Journal of Surgery 221:6, pages 1141-1149.
Crossref
Crossref
J. Eriksson, O. Norlén, M. Ögren, H. Garmo, C. Ihre-Lundgren & P. Hellman. (2019) Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops. Scandinavian Journal of Surgery 110:1, pages 44-50.
Crossref
Crossref
Sarah M. Wonn, Kristen E. Limbach, SuEllen J. Pommier, Anna N. Ratzlaff, E.J. Leon, Belinda H. McCully & Rodney F. Pommier. (2021) Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors. Surgery 169:1, pages 168-174.
Crossref
Crossref
Andrea Goldmann & Thomas Clerici. 2021. Endocrine Surgery Comprehensive Board Exam Guide. Endocrine Surgery Comprehensive Board Exam Guide
711
745
.
Oddry Folkestad, Hans H. Wasmuth, Patricia Mjønes, Reidun Fougner, Øyvind Hauso & Reidar Fossmark. (2020) Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital. Surgical Oncology 35, pages 336-343.
Crossref
Crossref
Giuseppe Fanciulli, Rosaria M. Ruggeri, Erika Grossrubatscher, Fabio Lo Calzo, Troy D. Wood, Antongiulio Faggiano, Andrea Isidori & Annamaria Colao. (2020) Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. Reviews in Endocrine and Metabolic Disorders 21:4, pages 599-612.
Crossref
Crossref
Yong-Jun Yu, Yu-Wei Li, Yang Shi, Zhao Zhang, Min-Ying Zheng & Shi-Wu Zhang. (2020) Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors. World Journal of Gastrointestinal Oncology 12:8, pages 893-902.
Crossref
Crossref
J. Eriksson, J. E. H. Garmo, C. Ihre-Lundgren & P. Hellman. (2018) Prognostic factors for death after surgery for small intestinal neuroendocrine tumours. BJS Open 2:5, pages 345-352.
Crossref
Crossref
Luis Felipe Fierro-Maya, Carolina Prieto, Gloria Garavito-G, Angélica María González-C, Yeinnyer Muleth & José Alexander Carreño. (2018) Resultados del tratamiento multidisciplinario de tumores neuroendocrinos de intestino delgado. Revista Colombiana de Cancerología 22:3, pages 105-111.
Crossref
Crossref
Olga D. Baranova, Pavel O. Roumiantsev, Konstantin Y. Slashchuk & Leonid O. Petrov. (2018) Radionuclide imaging and therapy in patients with neuroendocrine tumors. Endocrine Surgery 11:4, pages 178-190.
Crossref
Crossref
Faidon Marios Laskaratos, Leonidas Diamantopoulos, Martin Walker, Henry Walton, Mohamed Khalifa, Fatima El-Khouly, Apostolos Koffas, George Demetriou, Martyn Caplin, Christos Toumpanakis & Dalvinder Mandair. (2018) Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia. Neuroendocrinology 106:4, pages 366-380.
Crossref
Crossref
Federica Cavalcoli, Aoife Garrahy, Marco Castellaneta & Gianluca Tamagno. 2018. Neuroendocrine Tumors in Real Life. Neuroendocrine Tumors in Real Life
3
27
.
John Eriksson, Hans Garmo, Per Hellman & Catharina Ihre-Lundgren. (2016) The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors. Annals of Surgical Oncology 24:5, pages 1214-1220.
Crossref
Crossref
David L. Chan, Stephen J. Clarke, Connie I. Diakos, Paul J. Roach, Dale L. Bailey, Simron Singh & Nick Pavlakis. (2017) Prognostic and predictive biomarkers in neuroendocrine tumours. Critical Reviews in Oncology/Hematology 113, pages 268-282.
Crossref
Crossref
Eugene A. Woltering, Brianne A. Voros, David T. Beyer, Yi-Zarn Wang, Ramcharan Thiagarajan, Pamela Ryan, Anne Wright, Robert A. Ramirez, Jennifer M. Ricks & Philip J. Boudreaux. (2017) Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of the American College of Surgeons 224:4, pages 434-447.
Crossref
Crossref
Lunpo Wu, Jianfei Fu, Li Wan, Jie Pan, Sanchuan Lai, Jing Zhong, Daniel C. Chung & Liangjing Wang. (2016) Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Oncotarget 8:3, pages 4935-4947.
Crossref
Crossref
Sebastian Richards-Taylor, Sean M Ewings, Eleanor Jaynes, Charles Tilley, Sarah G Ellis, Thomas Armstrong, Neil Pearce & Judith Cave. (2016) The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis. Journal of Clinical Pathology 69:7, pages 612-618.
Crossref
Crossref
Tiantian Tian, Jing Gao, Na Li, Yanyan Li, Ming Lu, Zhongwu Li, Zhihao Lu, Jie Li & Lin Shen. (2016) Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors. PLOS ONE 11:5, pages e0154679.
Crossref
Crossref
Tine Gregersen, Christina Brock, Anne-Mette Haase, Søren Laurberg, Asbjørn M Drewes, Henning Grønbæk & Klaus Krogh. (2016) Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea. Journal of Neurogastroenterology and Motility 22:2, pages 264-271.
Crossref
Crossref
Laeeq Malik, Yu Jo Chua, Nadeem S Butt & Desmond Yip. (2013)
Single institutional series of neuroendocrine tumors managed in the
A
ustralian
C
apital
T
erritory
. Asia-Pacific Journal of Clinical Oncology 12:1.
Crossref
Crossref
B. Niederle, U.-F. Pape, F. Costa, D. Gross, F. Kelestimur, U. Knigge, K. Öberg, M. Pavel, A. Perren, C. Toumpanakis, J. O''Connor, D. O''Toole, E. Krenning, N. Reed & R. Kianmanesh. (2016) ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum. Neuroendocrinology 103:2, pages 125-138.
Crossref
Crossref
Ashley Kieran Clift, Omar Faiz, Adil Al-Nahhas, Andreas Bockisch, Marc Olaf Liedke, Erik Schloericke, Harpreet Wasan, John Martin, Paul Ziprin, Krishna Moorthy & Andrea Frilling. (2016) Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours. Journal of Gastrointestinal Surgery 20:1, pages 180-188.
Crossref
Crossref
Joo Young Kim, Ki-Suk Kim, Kyung-Jo Kim, In Ja Park, Jong Lyul Lee, Seung-Jae Myung, Yangsoon Park, Young Soo Park, Chang Sik Yu, Jin Cheon Kim, Eunsil Yu, Hyeung-Jin Jang & Seung-Mo Hong. (2015) Non-L-cell Immunophenotype and Large Tumor Size in Rectal Neuroendocrine Tumors Are Associated With Aggressive Clinical Behavior and Worse Prognosis. American Journal of Surgical Pathology 39:5, pages 632-643.
Crossref
Crossref
Swapnil D. Kachare, Kendall R. Liner, Nasreen A. Vohra, Emmanuel E. Zervos & Timothy L. Fitzgerald. (2014) A Modified Duodenal Neuroendocrine Tumor Staging Schema Better Defines the Risk of Lymph Node Metastasis and Disease-free Survival. The American Surgeon 80:8, pages 821-826.
Crossref
Crossref
Louis de Mestier, Clarisse Dromain, Gaspard d'Assignies, Jean-Yves Scoazec, Nathalie Lassau, Rachida Lebtahi, Hedia Brixi, Emmanuel Mitry, Rosine Guimbaud, Frédéric Courbon, Michèle d'Herbomez & Guillaume Cadiot. (2014) Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art. Endocrine-Related Cancer 21:3, pages R105-R120.
Crossref
Crossref
Marleny N. Figueiredo, Léon Maggiori, Sébastien Gaujoux, Anne Couvelard, Nathalie Guedj, Philippe Ruszniewski & Yves Panis. (2014) Surgery for small-bowel neuroendocrine tumors: Is there any benefit of the laparoscopic approach?. Surgical Endoscopy 28:5, pages 1720-1726.
Crossref
Crossref
Philip J. Boudreaux, Yi-Zarn Wang, Anne E. Diebold, Daniel J. Frey, Lowell Anthony, Ann Porter Uhlhorn, Pamela Ryan & Eugene A. Woltering. (2014) A Single Institution's Experience with Surgical Cytoreduction of Stage IV, Well-Differentiated, Small Bowel Neuroendocrine Tumors. Journal of the American College of Surgeons 218:4, pages 837-844.
Crossref
Crossref
Sara Massironi, Roberta Elisa Rossi, Giovanni Casazza, Dario Conte, Clorinda Ciafardini, Marianna Galeazzi & Maddalena Peracchi. (2014) Chromogranin A in Diagnosing and Monitoring Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Large Series from a Single Institution. Neuroendocrinology 100:2-3, pages 240-249.
Crossref
Crossref
Taofic Mounajjed, Michael Henry & Lizhi Zhang. (2014) Ki-67 Proliferative Index in Gastroenteropancreatic Neuroendocrine Neoplasms. Pathology Case Reviews 19:5, pages 256-260.
Crossref
Crossref
Shaunagh McDermott, Ailbhe C. O'Neill & Stephen J. Skehan. (2013) Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach. Clinical Imaging 37:2, pages 194-200.
Crossref
Crossref
Rajaventhan Srirajaskanthan, A. Ahmed, A. Prachialias, P. Srinivasan, N. Heaton, N. Jervis, A. Quaglia, G. Vivian & J. K. Ramage. (2013) ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours. ISRN Oncology 2013, pages 1-7.
Crossref
Crossref
Trude Haugland, Marijke Veenstra, Morten H. Vatn & Astrid K. Wahl. (2013) Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study. Nursing Research and Practice 2013, pages 1-9.
Crossref
Crossref
Christina L. Roland, Aihua Bian, John C. Mansour, Adam C. Yopp, Glen C. Balch, Rohit Sharma, Xian‐Jin Xie & Roderich E. Schwarz. (2011) Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. Journal of Surgical Oncology 105:6, pages 595-600.
Crossref
Crossref
Ulrich-Frank Pape, Aurel Perren, Bruno Niederle, David Gross, Thomas Gress, Frederico Costa, Rudolf Arnold, Timm Denecke, Ursula Plöckinger, Ramon Salazar & Ashley Grossman. (2012) ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas. Neuroendocrinology 95:2, pages 135-156.
Crossref
Crossref
Tine Gregersen, Nanna Holt, Henning Gronbaek, Ida Vogel, Lars J. Jørgensen & Klaus Krogh. (2012) Goblet Cell Carcinoid in a Patient with Neurofibromatosis Type 1: A Rare Combination. Case Reports in Gastrointestinal Medicine 2012, pages 1-3.
Crossref
Crossref
Lise Brehm Hoej, Karen Marie Nykjær & Henning Gronbaek. (2012) Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center. The Scientific World Journal 2012, pages 1-7.
Crossref
Crossref
K Landerholm, N Zar, R E Andersson, S E Falkmer & J Järhult. (2011) Survival and prognostic factors in patients with small bowel carcinoid tumour. British Journal of Surgery 98:11, pages 1617-1624.
Crossref
Crossref
M. d’Herbomez, C. Do Cao, D. Vezzosi, F. Borzon-Chasot & E. Baudin. (2010) Chromogranin A assay in clinical practice. Annales d'Endocrinologie 71:4, pages 274-280.
Crossref
Crossref